Professional Documents
Culture Documents
Marico LTD: A Safe Parachute!: Recommendation: BUY
Marico LTD: A Safe Parachute!: Recommendation: BUY
Marico LTD: A Safe Parachute!: Recommendation: BUY
Recommendation: BUY We are initiating coverage on Marico Ltd with a one-year price target of
CMP: Rs417 Rs522 –an upside of 25% from the current levels. The company operates
Target price: Rs522 in the personal care, wellness and processed edible oils categories in India
Upside: 25% as well as abroad and has a portfolio of 16 successful brands. The company
Market cap: Rs24.2bn dominates the Rs8bn branded coconut hair oil market with its flagship brand
Half yrly avg. Vol.: 32,090 – Parachute and holds No. 2 position in the Rs14bn edible oils market with
Face value: Rs10 its brands Saffola and Sweekar. It has also ventured into the skin care (Kaya)
and services (Sundari) business. We expect Marico to continue its growth
52 Week H/L: Rs587/237
momentum aided by acquisitions, international expansions and new
BSE code: 531642
launches. Given the strong position of the company in the hair care market
NSE code: MARICO
and good future prospects, we recommend a ‘BUY’.
Bloomberg code: MRCO@IN
Reuters code: MRCO.BO
Ø The acquisition of ‘Nihar’ brand from Hindustan Lever Ltd (HLL) has further
strengthened Marico’s position in the coconut oil segment and has enabled it
to become a clear leader in the perfumed coconut oil segment with a market
Share holding pattern share of 77%. While the company has paid a significant premium for the
acquisition, we believe it would be value accretive in the long run due to
March’06 (%)
broadened brand portfolio, enhanced market share and lower competition risk.
Promoters 66.6
Non Promoter Corp Holding 1.9
Institutions 10.8 Ø Marico was able to maintain MRP of Parachute, even during a declining copra
FIIs 14.2 price cycle, demonstrating its strong brand equity. Market share of Parachute
Public & Others 6.4 brand (including flexi packs) also improved by 2% yoy to over 51% during
FY06. Ability to sustain this pricing premium would enable Marico to move into
a higher profitability trajectory.
Share price chart Ø Maricoentered into the soaps segment via international (Camelia, Magnolia
BSE_SENSEX Marico and Aromatic brands in Bangladesh) and domestic (Manjal brand) acquisitions.
300 The company is currently prototyping personal care soap under the Parachute
250
200 brand. The contribution from the soap segment is currently miniscule but
150 expected to rise steadily.
100
50
0 Ø Skin care service venture - Kaya recorded a turnover of Rs480mn during FY06
Jun-05
Jun-06
Sep-05
Dec-05
Mar-06
and is expected to break even at PBT level in FY07. The Sundari business will
remain in the investment phase and is unlikely to breakeven over the next two
years.
Investment rationale
Successful realignment of product portfolio
Over the last few years, Marico has reduced its focus on the low margin products
and invested more in the high margin products. As a result, contribution of the
high margin portfolio has increased from 72% in FY05 to 76% in FY06 while the
contribution of low margin portfolio has decreased to 24% from 30% last year.
Marico’s high-margin brands such as Parachute, Saffola and the hair care range
registered double-digit volume CAGR over the past four years and grew by 11%,
10% and 16% respectively during FY06.
Contribution (%)
90
80
70
60
50
40
30
20
FY03 FY04 FY05 FY06
High margin Low margin
The company has allocated nearly 95% of the total advertising & sales promotion
spends to this portfolio. The strategy has yielded returns in terms of improved
profitability. Operating margins of the company expanded sharply by 440bps to
13.3% during FY06. Marico now has a well-diversified product portfolio with many
successful brands – hair care (Parachute, Hair & Care, Shanti, Mediker, Oil of Malabar
(slowly defocussing)), soaps (Camelia, Magnolia, Aromatic and Manjal), edible oils
(Saffola, Sweekar (slowly defocusing)), foods (Mealmaker, Sil), fabric care (Revive)
and branded services (Kaya and Sundari). The company has also forayed into
categories such as hair conditioners (Silk-n-Shine), male grooming products
(Parachute After Shower Cream) and baby care (Sparsh baby oil) during the year.
As a result of this diversification, Marico’s dependence on the Parachute brand has
consistently reduced from 70-75% of the topline in early 90’s to ~40-45% in FY06.
5000 46
44
4500
(Rs mn)
42
(%)
4000
40
3500 38
3000 36
2001 2002 2003 2004 2005
Coconut oil sales Market share
Source: AC Nielsen
Despite declining prices of copra (lower by ~25%), the company was able to
maintain the MRP of Parachute during the year, reflecting the strong pricing power
of the brand. Lower raw material prices (expected to remain weak in FY07 also)
have also enabled a sharp 480bps margin improvement during the year. Improving
pricing power and Nihar acquisition have strengthened Marico’s position in the
hair care market. We believe that going forward if Marico displays ability to maintain
MRP, operating margins could be sustained at the current high levels.
Others
Clinic 2%
22% Nihar
Naturals
51%
Parachute
Jasmine
25%
Source: Industry
Particulars Rs mn
Nihar acquisition 2,300
Expansion of Kaya 400
Brand building 300
Building (New corporate office) 600
Total 3,600
Source: Company
Concerns
Rising raw material prices and higher adspend could prune down margins
During FY06, Marico’s operating margins expanded significantly by 440bps to
13.3% aided by ~25% drop in raw material prices. Copra, Safflower, Sunflower,
Kardi are the key raw materials for Marico. For the past 1.5-2 years, the copra
prices are ruling weak and are expected to remain fairly stable during the year.
However, if the raw material prices start firming up and if there is lack of availability
(in FY03, Saffola sales were impacted due to inadequate availability of Kardi oil),
the company will witness a sharp dip in its operating margins. Higher packaging
cost (8.6% of sales in FY06) on account of rising crude oil prices will also restrict
margin expansion.
OPM
15.0
13.3 13.7 13.7
12.5 10.8
9.6
8.4 8.9
(%)
10.0
7.5
5.0
FY07P
FY08P
FY02
FY03
FY04
FY05
Marico has a clutch of high contribution new products in the pipeline, which are
being successfully prototyped and are likely to be launched in the near future.
Initially these products will remain in the investment stage where the company
will have to invest heavily in advertising and sales promotion. Thus, the rising
adspend will also put pressure on margins.
15.0 15.0
12.5 12.5
(%)
(%)
10.0 10.0
7.5 7.5
5.0 5.0
2.5 2.5
Q1 FY04
Q2 FY04
Q3 FY04
Q4 FY04
Q1 FY05
Q2 FY05
Q3 FY05
Q4 FY05
Q1 FY06
Q2 FY06
Q3 FY06
Q4 FY06
Valuations
Marico has reported 10.9% sales growth at Rs10.4bn and 34% PAT growth at
Rs989mn in FY06. We expect Marico’s revenues to grow at a CAGR of 22.1% and
net profit at a CAGR of 22.9% over the next two years. Our FY07 sales forecast is
based on assumption of 12% growth in edible oil segment, 15% growth in hair
oil segment (+ revenues from Nihar) and 2% growth in others segment (incl.
Processed foods + revenues from Manjal). At the current market price of Rs417,
the stock is trading at 20.3x FY07E EPS of Rs20.6 and 16.2x FY08E EPS of Rs25.7.
We initiate coverage with a one-year price target of Rs522 – an upside of 25%
from the current levels.
Company background
Marico Ltd, formerly known as Marico Industries Ltd, was incorporated in the
year 1988. It is a closely held company of the Mariwala family and is headed by
Harsh Mariwala, Chairman & Managing Director. Marico commenced its operations
by taking over the consumer products division of Bombay Oil Industries Ltd in the
year 1990. Marico’s brands and their extensions occupy leadership positions
with significant market shares in respective categories - coconut oil, hair oils,
anti-lice treatment, premium refined edible oils and fabric care. The company has
also entered the skin care segment through Kaya Skin Clinics in India and Sundari
range of Ayurvedic skin care products in the US and in soaps business by acquiring
Camelia, Magnolia and Aromatic brands in Bangladesh and Manjal brand in India.
Marico has also successfully built an international business spread over 18
countries - the Middle East and the Asian sub-continent, especially Bangladesh.
The overseas sales franchise of Marico’s consumer products is one of the largest
amongst Indian companies. Marico’s presence overseas (whether as exports
from India or as local operations in a foreign country) is entirely through branded
services and branded FMCG products.
Business
Marico started its business with just two major brands: Parachute and Saffola.
The portfolio is now expanded to 16 strong brands Parachute, Nihar, Saffola,
Sweekar, Hair & Care, Shanti, Mediker, Oil of Malabar, Mealmaker, Sil, Revive,
Kaya, Sundari, Camelia, Magnolia and Aromatic.
Domestic turnover accounts for almost 89% of the total turnover of Marico group.
Revenue breakup generated from each of the businesses is depicted in the chart
below:
Management Profile
Name Designation
Harsh Mariwala Chairman & Managing Director
Bipin Shah Director
Nikhil Khattau Director
Atul Choksey Director
Rajeev Bakshi Director
Rajen Mariwala Director
Jacob Kurian Additional Director
Hema Ravichandar Additional Director
Milind Sarwate Chief Financial Officer
June 23, 2006 9
Marico Ltd: A Safe Parachute!
Industry
Hair oils
33%
Chart: Hair oil segment Chart: Company-wise market share in hair oil
Bajaj
10,500
(%)
8.0 8%
10,000
6.0
9,500
9,000 4.0
8,500 2.0
8,000 - Others Marico
2001 2002 2003 2004 2005 19% 21%
Source: AC Nielsen Source: Industry, Nihar’s share will get added to Marico
40000 40.0
35000 35.0
30.0
30000
25.0
(Rs mn)
25000
(%)
20.0
20000
15.0
15000
10.0
10000 5.0
5000 -
2000 2001 2002 2003 2004 2005
Source: AC Nielsen
Financials
Uses
Gross Block 1,525 1,704 4,020 4,220 4,420
Accd Depreciation (703) (813) (1,145) (1,441) (1,750)
Net Block 822 891 2,875 2,779 2,670
Capital WIP 76 117 252 130 150
Total Fixed Assets 898 1,008 3,126 2,909 2,820
Investments 144 291 205 180 220
Total Current Assets 1,893 2,628 2,956 3,237 3,715
Total Current Liabilities (979) (1,156) (1,222) (1,500) (1,760)
Net Working Capital 914 1,471 1,735 1,737 1,954
Total 1,956 2,770 5,066 4,827 4,994
We have exercised due diligence in checking the correctness and authenticity of the information contained herein, but do not
represent that it is accurate or complete. IIL or any of its subsidiaries or associates or employees shall not be in any way
responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this
publication. The recipients of this report should rely on their own investigations. IIL and/or its subsidiaries and/or directors,
employees or associates may have interests or positions, financial or otherwise in the securities mentioned in this report.
India Infoline Ltd, 15th Floor, P. J. Towers, Dalal Street, Fort, Mumbai - 400 001. Tel 6749 1700. Fax 2272 2419
India Infoline Research can be also accessed on Bloomberg (Code IILL), Thomson First Call and ISI Emerging markets.